It was reported that the deficiency of CERK suppressed inflammation in adipose tissue through attenuating MCP-1/CCR2 signaling in infiltrated macrophages and improved insulin resistance, pinpointing CERK as a potential therapeutic target for the treatment of obesity and insulin resistance7. This evidence concerns the gene CCL2 and obesity disorder.